Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer (2016)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; LEITE, KATIA RAMOS MOREIRA - FM
- Unidade: FM
- Subjects: NEOPLASIAS PROSTÁTICAS; EXPRESSÃO GÊNICA; PROSTÁTA (CIRURGIA); RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Laboratory investigation
- ISSN: 0023-6837
- Volume/Número/Paginação/Ano: v. 96, suppl. 1, p. 250A-251A, res. 998, 2016
- Conference titles: Annual Meeting of the United States and Canadian Academy of Pathology
-
ABNT
MOURA, Caio M. et al. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf. Acesso em: 18 fev. 2026. , 2016 -
APA
Moura, C. M., Reis, S. T., Pontes, J., Viana, N., Dip, N., Srougi, M., & Leite, K. R. M. (2016). Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf -
NLM
Moura CM, Reis ST, Pontes J, Viana N, Dip N, Srougi M, Leite KRM. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer [Internet]. Laboratory investigation. 2016 ; 96 250A-251A.[citado 2026 fev. 18 ] Available from: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf -
Vancouver
Moura CM, Reis ST, Pontes J, Viana N, Dip N, Srougi M, Leite KRM. Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer [Internet]. Laboratory investigation. 2016 ; 96 250A-251A.[citado 2026 fev. 18 ] Available from: http://www.nature.com/labinvest/journal/v96/n1s/pdf/labinvest201610a.pdf - Treating metastatic prostate cancer with microRNA-145
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Prognostic value of TERF1 expression in prostate cancer
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer
- Histologic abnormalities in non-neoplastic renal parenchyma and the risk of chronic kidney disease following radical nephrectomy
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
- Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology
- Digital application developed to evaluate functional results following robot-assisted radical prostatectomy* App for prostate cancer
- Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
